Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activity https://www.biorxiv.org/content/10.1101/2023.05.03.539272v1?med=mas
Engineered cytokine/antibody fusion proteins improve delivery of IL-2 to pro-inflammatory cells and promote antitumor activity https://www.biorxiv.org/content/10.1101/2023.05.03.539272v1?med=mas